Abstract:Abstract Influenza A viruses cause widespread human respiratory disease. The viral multifunctional NS1 protein inhibits host antiviral responses. This inhibition results from the binding of specific cellular antiviral proteins at various positions on the NS1 protein. Remarkably, binding of several proteins also requires the two amino-acid residues in the NS1 N-terminal RNA-binding domain (RBD) that are required for binding double-stranded RNA (dsRNA). Here we focus on the host restriction factor DHX30 helicase that is countered by the NS1 protein, and establish why the dsRNA-binding activity of NS1 is required for its binding to DHX30. We show that the N-terminal 152 amino-acid residue segment of DHX30, denoted DHX30N, possesses all the antiviral activity of DHX30 and contains a dsRNA-binding domain, and that the NS1-DHX30 interaction in vivo requires the dsRNA-binding activity of both DHX30N and the NS1 RBD. We demonstrate why this is the case using bacteria-expressed proteins: the DHX30N-NS1 RBD interaction in vitro requires the presence of a dsRNA platform that binds both NS1 RBD and DHX30N. We propose that a similar dsRNA platform functions in interactions of the NS1 protein with other proteins that requires these same two amino-acid residues required for NS1 RBD dsRNA-binding activity.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how Influenza A virus interacts with the DHX30 helicase in host cells through its non - structural protein 1 (NS1 protein), thereby inhibiting the host's antiviral response. Specifically, the study focused on the interaction mechanism between the NS1 protein and DHX30, especially why the existence of a double - stranded RNA (dsRNA) platform is required for this interaction. Through this study, the authors hope to reveal how the NS1 protein uses specific amino acid residues (especially arginine at position 38 and lysine at position 41) to bind to dsRNA and further interact with DHX30, thereby exerting its function of inhibiting the host's antiviral response. ### Research Background - **Influenza A virus**: It causes a wide range of human respiratory diseases, resulting in a large number of infections every year and has the potential to trigger highly lethal pandemics. - **NS1 protein**: It is a multifunctional non - structural protein of Influenza A virus, which can inhibit the host's antiviral response, regulate other cellular and viral functions, and affect virus virulence and virus - induced pathological processes. - **DHX30**: It is an intracellular RNA helicase with antiviral activity and can interact with the NS1 protein, but the specific molecular mechanism of this interaction is still unclear. ### Research Objectives - **Reveal the interaction mechanism between the NS1 protein and DHX30**: Especially why the participation of the dsRNA platform is required for this interaction. - **Determine which amino acid residues in the NS1 protein are crucial for binding to DHX30**: Especially the roles of arginine at position 38 (Arg38) and lysine at position 41 (Lys41) in this process. - **Verify whether the N - terminal fragment of DHX30 is sufficient to bind to the NS1 protein and inhibit virus replication**: Especially whether the 152 - amino - acid - residue fragment at the N - terminal of DHX30 (DHX30N) has complete antiviral activity. ### Main Findings - **DHX30 inhibits the replication of Influenza A virus**: Through siRNA knockdown experiments, it was proved that DHX30 can significantly inhibit the replication of Influenza A virus. - **Interaction between the NS1 protein and DHX30**: Through GST pulldown experiments, it was confirmed that the NS1 protein can specifically bind to DHX30, and this binding is independent of the existence of single - stranded RNA. - **Roles of key amino acid residues**: Through mutation experiments, it was found that the R38 and K41 residues of the NS1 protein are crucial for binding to DHX30, and these residues are also necessary for the NS1 protein to bind to dsRNA. - **Function of the DHX30N fragment**: The 152 - amino - acid - residue fragment at the N - terminal of DHX30 (DHX30N) can not only bind to the NS1 protein but also has the same antiviral activity as the full - length DHX30. ### Conclusions - **Role of the dsRNA platform in the interaction between the NS1 protein and DHX30**: The interaction between the NS1 protein and DHX30 requires a dsRNA platform, which can bind to the RBD of the NS1 protein and DHX30N simultaneously. - **Importance of the R38 and K41 residues of the NS1 protein**: These residues are not only crucial for the NS1 protein to bind to dsRNA but also key to the interaction between the NS1 protein and DHX30. - **Antiviral activity of the DHX30N fragment**: The DHX30N fragment has complete antiviral activity, indicating that the N - terminal region of DHX30 is the core of its antiviral function. Through these findings, the paper provides an important molecular mechanism for understanding how Influenza A virus inhibits the host's antiviral response through the NS1 protein.

A double-stranded RNA platform is required for the interaction between a host restriction factor and the NS1 protein of influenza A virus

Influenza Virus NS1 Protein RNA-Interactome Reveals Intron Targeting.

Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon

The NS1 protein of influenza B virus binds 5’-triphosphorylated dsRNA to suppress RIG-I activation and the host antiviral response

XAF1 Protects Host Against RNA Viruses&nbsp;by Stabilizing IRF1-Dependent Antiviral Immunity

Identification of RNA Helicase A As a Cellular Factor That Interacts with Influenza A Virus NS1 Protein and Its Role in the Virus Life Cycle

DDX3X Coordinates Host Defense Against Influenza Virus by Activating the NLRP3 Inflammasome and Type I Interferon Response

The Interaction of Influenza A NS1 and Cellular TRBP Protein Modulates the Function of RNA Interference Machinery

Structural basis for influenza virus NS1 protein block of mRNA nuclear export

Exploring the molecular basis of dsRNA recognition by NS1 protein of influenza A virus using molecular dynamics simulation and free energy calculation.

Influenza Virus NS1 Interacts with 14-3-3ε to Antagonize the Production of RIG-I-mediated Type I Interferons.

The N-terminal Residual Arginine19 of Influenza A Virus NS1 Protein is Required for Its Nuclear Localization and RNA Binding.

Avian Influenza NS1 Proteins Inhibit Human, but Not Duck, RIG-I Ubiquitination and Interferon Signaling

Interactome Profiling of N-Terminus-Truncated NS1 Protein of Influenza A Virus Reveals Role of 14-3-3γ in Virus Replication

Theoretical Investigations on the Effects of Mutations in Important Residues of NS1B on Its RNA-binding Using Molecular Dynamics Simulations.

Role of CIV NS1 Protein in Innate Immunity and Viral Replication

Structural Basis of Human Helicase DDX21 in RNA Binding, Unwinding, and Antiviral Signal Activation

The C-Terminal Effector Domain of Non-Structural Protein 1 of Influenza A Virus Blocks IFN-β Production by Targeting TNF Receptor-Associated Factor 3

Mutations at site 207 of influenza a virus NS1 protein switch its function in regulating RIG-I-like receptors mediated antiviral responses

[Study Progress of NS1 Protein of Influenza A Virus].

NS2 induces an influenza A RNA polymerase hexamer and acts as a transcription to replication switch